Escitalopram for treatment of night eating syndrome: A 12-Week, randomized, placebo-controlled trial

Journal of Clinical Psychopharmacology

Volumn 32, Issue 3, 2012, Pages 341-345

  Vander Wal, Jillon S ^a   Gang, Catherine H ^c   Griffing, George T ^b   Gadde, Kishore M ^c  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

eating disorders; escitalopram; night eating syndrome; randomized controlled trial; selective serotonin reuptake inhibitors

Indexed keywords

CHOLESTEROL; ESCITALOPRAM; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; BINGE EATING DISORDER; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; ERECTILE DYSFUNCTION; EUROPEAN AMERICAN; EVENING DOSAGE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MEDICAL HISTORY; MENTAL CONCENTRATION DIFFICULTY; MENTAL DISEASE; MOOD; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NIGHT EATING QUESTIONNAIRE; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SOMNOLENCE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UPPER RESPIRATORY TRACT INFECTION;

ACADEMIC MEDICAL CENTERS; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BODY MASS INDEX; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; EATING DISORDERS; FEMALE; HUMANS; HYPERPHAGIA; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PLACEBO EFFECT; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84861033148     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318254239b     Document Type: Article

References (37)

1. Stunkard AJ, Grace WJ, Wolff HG. The night-eating syndrome: A pattern of food intake among certain obese individuals. Am J Med. 1955;19:78-88.
2. Stunkard AJ, Allison KC. Two forms of disordered eating in obesity: Binge eating and night eating. Int J Obes. 2003;27:1-12.
3. Birketvedt GS, Florholmen J, Sundfjord J, et al. Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA. 1999;282(7):657-663.
4. Rand CSW, Kuldau JM. Morbid obesity: A comparison between a general population and obesity surgery patients. Int J Obes Relat Metab Disord. 1993;17(11):657-661.
5. Rand CSW, Macgregor AMC, Stunkard AJ. The night eating syndrome in the general population and among postoperative obesity surgery patients. Int J Eat Disord. 1997;22:65-69.
6. Kuldau JM, Rand CSW. The night eating syndrome and bulimia in the morbidly obese. Int J Eat Disord. 1986;5(1):143-148.
7. Hsu LKG, Betancourt S, Sullivan SP. Eating disturbances before and after vertical banded gastroplasty: A pilot study. Int J Eat Disord. 1996;19:23-34.
8. Powers PS, Perez A, Boyd F, et al. Eating pathology before and after bariatric surgery: A prospective study. Int J Eat Disord. 1999;25:293-300.
9. Stunkard AJ, Berkowtiz R, Wadden T, et al. Binge eating disorder and the night eating syndrome. Int J Obes. 1996;20:1-6.
10. Manni R, Ratti MT, Tartara A. Nocturnal eating: Prevalence and features in 120 insomnia referrals. Sleep. 1997;20(9):734-738.
11. Lundgren JD, Allison KC, Crow S. Prevalence of the night eating syndrome in a psychiatric population. Am J Psychiatry. 2006;163:156-158.
12. Lundgren JD, Allison KD, Stunkard AJ. Familial aggregation in the night eating syndrome. Int J Eat Disord. 2006;39:1-3.
13. Allison KC, Stunkard AJ, Their SL. Overcoming Night Eating Syndrome: A Step-by-Step Guide to Breaking the Cycle. Oakland, CA: New Harbinger; 2004.
14. Spaggiari MC, Granella F, Parrino L, et al. Nocturnal eating syndrome in adults. Sleep. 1994;17(4):339-344.
15. Gluck ME, Geliebter A, Satov T. Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger, and less weight loss in obese outpatients. Obes Res. 2001;9:264-267.
16. Miyaoka T, Yasukawa R, Tsubouchi K, et al. Successful treatment of nocturnal eating/drinking syndrome with selective serortonin reuptake inhibitors. Int J Clin Psychopharm. 2003;18:175-177.
17. Winkelman JW. Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate. Sleep Med. 2003;4:243-246.
18. O'Reardon JP, Stunkard AJ, Allison KC. Clinical trial of sertraline in the treatment of night eating syndrome. Int J Eat Disord. 2004;35:16-26.
19. O'Reardon JP, Allison KC, Martino NS, et al. A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome. Am J Psychiatry. 2006;163:893-898.
20. Guy W. Clinical Global Impressions (028-CGI). In: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976:217-222.
21. Stunkard AJ, Allison KC, Lundgren JD, et al. A paradigm for facilitating pharmacotherapy at a distance: Sertraline treatment of the night eating syndrome. J Clin Psychiatry. 2006;67:1568-1572.
22. Flament MF, Bissada H, Spettigue W. Evidence-based pharmacotherapy of eating disorders. Int J Neuropsychopharmacol. 2012;15:189-207.
23. Reas DL, Grilo CM. Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity. 2008;16:2024-2038.
24. Allison KC, Lundgren JD, O'Reardon JP, et al. The Night Eating Questionnaire (NEQ): Psychometric properties of a measure of severity of the Night Eating Syndrome. Eat Behav. 2008;9:62-72.
25. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33.
26. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition (SCID-I/NP). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
27. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory II. San Antonio, TX: Harcourt Brace; 1996.
28. Beck AT, Steer RA. Manual for the Beck Anxiety Inventory. San Antonio, TX: Harcourt Brace; 1993.
29. Johnson BT. DSTAT Software for the Meta-analytic Review of Research Literatures. Version 1.11. Hillsdale, NJ: Lawrence Erlbaum Associates; 1993.
30. Faul F, Erdfelder E. GPOWER: A Priori, Post-Hoc, and Compromise Power Analyses for MS-DOS. Version 2.00 [Computer Program]. Bonn, Germany: Bonn University, Department of Psychology; 1992.
31. Cohen J. A power primer. Psychol Bull. 1992;112(1):155-159.
32. Vander Wal JS, Waller SM, Klurfeld DM, et al. Night eating syndrome: Evaluation of two screening instruments. Eat Behav. 2005;6(1):63-73.
33. Goodnick PJ, Goldstein BJ. Selective serotonin reuptake inhibitors in affective disordersV1. Basic pharmacology. J Psychopharmacol. 1998;12:S5-S20.
34. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: Implications for clinical practice. Am J Psychiatry. 2006;163:28-40.
35. Friedman ES, Wisniewski SR, Gilmer W, et al. Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: Results of the NIMH STARD trial. Depress Anxiety. 2009;26:612-621.
36. Binder EB, Owens MJ, Liu W, et al. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Arch Gen Psychiatry. 2010;67:369-379.
37. Allison KC, Lundgren JD, O'Reardon JP, et al. Proposed diagnostic criteria for night eating syndrome. Int J Eat Disord. 2010;43:241-247.